|
2026-08-18 |
2026-08-18 |
B
Purchase
|
CEO, President
Executive Director
Large shareholder
|
13,316
+32.5%
401.83
US$4,348,756
|
13,316
+32.5%
|
401.83
|
US$4,348,756
|
|
|
2026-08-18 |
2026-08-17 |
B
Purchase
|
CEO
Executive Director
Large shareholder
|
1,790
+47.9%
408.74
US$4,991,259
|
1,790
+47.9%
|
408.74
|
US$4,991,259
|
|
|
2026-08-17 |
2026-08-17 |
B
Purchase
|
CEO, President
Executive Director
Large shareholder
|
34,903
+33.3%
331.25
US$953,266
|
34,903
+33.3%
|
331.25
|
US$953,266
|
|
|
2026-08-18 |
2026-08-14 |
B
Purchase
|
CEO
Executive Director
Large shareholder
|
1,000
+6.2%
3.85
US$100,000
|
1,000
+6.2%
|
3.85
|
US$100,000
|
|
|
2026-08-17 |
2026-08-14 |
B
Purchase
|
CEO, President
Executive Director
Large shareholder
|
1,000
+0.4%
3.79
US$100,000
|
1,000
+0.4%
|
3.79
|
US$100,000
|
|
|
2026-05-04 |
2026-05-01 |
B
Purchase
|
President
Executive Director
Large shareholder
|
10,000
+0.3%
4.16
US$41,592
|
10,000
+0.3%
|
4.16
|
US$41,592
|
|
|
2026-04-28 |
2026-04-28 |
B
Purchase
|
President
Executive Director
Large shareholder
|
10,000
+0.3%
4.52
US$45,180
|
10,000
+0.3%
|
4.52
|
US$45,180
|
|
|
2026-04-24 |
2026-04-23 |
B
Purchase
|
Chief Clinical Officer
Officer
|
500
+0.4%
4.88
US$2,440
|
500
+0.4%
|
4.88
|
US$2,440
|
|
|
2026-04-23 |
2026-04-23 |
B
Purchase
|
President
Executive Director
Large shareholder
|
10,000
+0.3%
4.90
US$49,000
|
10,000
+0.3%
|
4.90
|
US$49,000
|
|
|
2026-04-10 |
2026-04-10 |
B
Purchase
|
President
Executive Director
Large shareholder
|
10,000
+0.3%
4.90
US$48,950
|
10,000
+0.3%
|
4.90
|
US$48,950
|
|
|
2026-04-13 |
2026-04-09 |
B
Purchase
|
Chief Accounting Officer
Officer
|
200
+0.2%
5.00
US$1,000
|
200
+0.2%
|
5.00
|
US$1,000
|
|
|
2026-04-09 |
2026-04-09 |
B
Purchase
|
President
Executive Director
Large shareholder
|
5,000
+0.2%
5.19
US$25,950
|
5,000
+0.2%
|
5.19
|
US$25,950
|
|
|
2026-04-09 |
2026-04-08 |
B
Purchase
|
President
Executive Director
Large shareholder
|
10,000
+0.3%
5.61
US$56,050
|
10,000
+0.3%
|
5.61
|
US$56,050
|
|
|
2026-04-06 |
2026-04-06 |
B
Purchase
|
President
Executive Director
Large shareholder
|
5,000
+0.2%
6.32
US$31,600
|
5,000
+0.2%
|
6.32
|
US$31,600
|
|
|
2026-04-06 |
2026-04-02 |
B
Purchase
|
President
Executive Director
Large shareholder
|
20,000
+0.7%
6.09
US$121,798
|
20,000
+0.7%
|
6.09
|
US$121,798
|
|
|
2025-11-24 |
2025-11-24 |
B
Purchase
|
President
Executive Director
Large shareholder
|
6,000
+0.2%
6.51
US$39,060
|
6,000
+0.2%
|
6.51
|
US$39,060
|
|
|
2025-11-24 |
2025-11-21 |
B
Purchase
|
President
Executive Director
Large shareholder
|
4,000
+0.1%
6.50
US$26,000
|
4,000
+0.1%
|
6.50
|
US$26,000
|
|
|
2025-11-24 |
2025-11-21 |
B
Purchase
|
President
Executive Director
Large shareholder
|
20,000
+0.7%
5.98
US$119,600
|
20,000
+0.7%
|
5.98
|
US$119,600
|
|
|
2025-11-24 |
2025-11-20 |
B
Purchase
|
Chief Clinical Officer
Officer
|
1,100
+0.8%
6.69
US$7,359
|
1,100
+0.8%
|
6.69
|
US$7,359
|
|
|
2025-05-23 |
2025-05-23 |
B
Purchase
|
President
Executive Director
|
2,000
+0.1%
7.39
US$14,785
|
2,000
+0.1%
|
7.39
|
US$14,785
|
|
|
2025-05-23 |
2025-05-22 |
B
Purchase
|
CEO
Executive Director
Large shareholder
|
2,709
+0.5%
7.38
US$20,000
|
2,709
+0.5%
|
7.38
|
US$20,000
|
|
|
2025-05-23 |
2025-05-22 |
B
Purchase
|
CFO
Officer
|
675
+0.3%
7.29
US$4,921
|
675
+0.3%
|
7.29
|
US$4,921
|
|
|
2025-05-23 |
2025-05-21 |
B
Purchase
|
CEO
Executive Director
Large shareholder
|
2,759
+0.5%
7.25
US$20,002
|
2,759
+0.5%
|
7.25
|
US$20,002
|
|
|
2025-05-22 |
2025-05-19 |
B
Purchase
|
CFO
Officer
|
135
+0.1%
7.23
US$976
|
135
+0.1%
|
7.23
|
US$976
|
|
|
2025-05-19 |
2025-05-16 |
B
Purchase
|
President
Executive Director
|
3,510
+0.2%
16.87
US$59,221
|
3,510
+0.2%
|
16.87
|
US$59,221
|
|
|
2025-05-19 |
2025-05-15 |
B
Purchase
|
President
Executive Director
|
1,500
+0.1%
7.30
US$10,945
|
1,500
+0.1%
|
7.30
|
US$10,945
|
|
|
2025-05-19 |
2025-05-14 |
B
Purchase
|
President
Executive Director
|
1,000
+0.1%
7.27
US$7,267
|
1,000
+0.1%
|
7.27
|
US$7,267
|
|
|
2025-05-19 |
2025-05-13 |
B
Purchase
|
President
Executive Director
|
990
+0.1%
7.01
US$6,942
|
990
+0.1%
|
7.01
|
US$6,942
|
|
|
2025-05-19 |
2025-05-12 |
B
Purchase
|
Non-Executive Director
|
5,000
+9.9%
7.22
US$36,110
|
5,000
+9.9%
|
7.22
|
US$36,110
|
|
|
2025-05-19 |
2025-05-12 |
B
Purchase
|
CEO
Executive Director
Large shareholder
|
400
+0.1%
7.00
US$2,800
|
400
+0.1%
|
7.00
|
US$2,800
|
|
|
2025-05-19 |
2025-05-12 |
B
Purchase
|
President
Executive Director
|
1,400
+0.1%
7.23
US$10,124
|
1,400
+0.1%
|
7.23
|
US$10,124
|
|
|
2025-05-19 |
2025-05-11 |
B
Purchase
|
President
Executive Director
|
1,600
+0.1%
7.51
US$12,016
|
1,600
+0.1%
|
7.51
|
US$12,016
|
|
|
2025-05-19 |
2025-04-17 |
B
Purchase
|
Non-Executive Director
|
50
+0.1%
6.92
US$346
|
50
+0.1%
|
6.92
|
US$346
|
|
|
2026-04-24 |
2025-04-15 |
B
Purchase
|
CFO
Officer
|
300
+0.1%
5.38
US$1,614
|
300
+0.1%
|
5.38
|
US$1,614
|
|
|
2025-05-19 |
2025-03-26 |
B
Purchase
|
Non-Executive Director
|
50
+0.1%
16.05
US$802
|
50
+0.1%
|
16.05
|
US$802
|
|